| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
B Activation by an Anti-Ras Single-Chain Antibody Fragment
Molecular Radiation Therapeutics Branch, Radiation Oncology Science Program, National Cancer Institute, Bethesda, Maryland 20892 [J. S. R., P. J. T.]; Departments of Experimental Radiation Oncology [J. S. R., U. R., G. J. G., P. J. T.] and Neurosurgery [F. F. L., P. J. T.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030; Introgen Therapeutics, Inc., Houston, Texas 77054 [D. R. W.]; and Aventis Pharmaceuticals, Hayward, California 94540 [T. H.]
We have shown previously that the transduction of a number of human tumor cell lines with an adenovirus (AV1Y28) expressing a single-chain antibody fragment (scFv) directed against Ras proteins results in radiosensitization. Because Ras is involved in the regulation of a number of transcription factors, we have determined the effects of this adenovirus on the activation of nuclear factor-
B (NF-
B), a radiation-responsive transcription factor associated with cell survival. In U251 human glioma cells, radiation-induced NF-
B was significantly attenuated by prior transduction of the anti-Ras scFv adenovirus. This effect appeared to involve an inhibition of I
B kinase activity and I
B
phosphorylation. Inhibitors to the Ras effectors mitogen-activated protein kinase kinase, phosphatidylinositol 3-kinase, and p38, however, did not reduce radiation-induced NF-
B. Whereas AV1Y28 inhibited NF-
B activation by hydrogen peroxide and ferricyanide, it had no effect of tumor necrosis factor-
-induced NF-
B activation. These results are consistent with a novel Ras-dependent, oxidant-specific signaling pathway mediating the activation of NF-
B. In additional cell lines radiosensitized by AV1Y28, radiation-induced NF-
B activation was also inhibited by the anti-Ras scFv, whereas in cell lines not radiosensitized, radiation did not activate NF-
B. This correlation suggested that AV1Y28-mediated radiosensitization involved the inhibition of radiation-induced NF-
B activation. However, inhibition of NF-
B activation via the expression of a dominant-negative form of I
B
in U251 cells had no effect on radiation-induced cell killing and did not influence AV1Y28-mediated radiosensitization. Therefore, whereas AV1Y28 inhibits radiation-induced NF-
B activation, this process does not appear to play a direct role in its radiosensitizing actions.
This article has been cited by other articles:
![]() |
S. Kunigal, S. S. Lakka, P. Joseph, N. Estes, and J. S. Rao Matrix metalloproteinase-9 Inhibition Down-Regulates Radiation-Induced Nuclear Factor-{kappa}B Activity Leading to Apoptosis in Breast Tumors Clin. Cancer Res., June 1, 2008; 14(11): 3617 - 3626. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Camphausen and P. J. Tofilon Inhibition of Hsp90: A Multitarget Approach to Radiosensitization Clin. Cancer Res., August 1, 2007; 13(15): 4326 - 4330. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dote, D. Cerna, W. E. Burgan, K. Camphausen, and P. J. Tofilon ErbB3 Expression Predicts Tumor Cell Radiosensitization Induced by Hsp90 Inhibition Cancer Res., August 1, 2005; 65(15): 6967 - 6975. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Y. Kim, K. A. Kim, O. Kwon, S. O. Kim, M. S. Kim, B. S. Kim, W. K. Oh, G. D. Kim, M. Jung, and J. S. Ahn NF-{kappa}B inhibition radiosensitizes Ki-Ras-transformed cells to ionizing radiation Carcinogenesis, August 1, 2005; 26(8): 1395 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Caron, A. Yacoub, X. Zhu, C. Mitchell, S. I. Han, T. Sasazuki, S. Shirasawa, M. P. Hagan, S. Grant, and P. Dent H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent Mol. Cancer Ther., February 1, 2005; 4(2): 243 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Caron, A. Yacoub, M. Li, X. Zhu, C. Mitchell, Y. Hong, W. Hawkins, T. Sasazuki, S. Shirasawa, A. P. Kozikowski, et al. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival Mol. Cancer Ther., February 1, 2005; 4(2): 257 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Camphausen, K. J. Brady, W. E. Burgan, M. A. Cerra, J. S. Russell, E. E.A. Bull, and P. J. Tofilon Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of {gamma}H2AX foci Mol. Cancer Ther., April 1, 2004; 3(4): 409 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Russell, K. Brady, W. E. Burgan, M. A. Cerra, K. A. Oswald, K. Camphausen, and P. J. Tofilon Gleevec-Mediated Inhibition of Rad51 Expression and Enhancement of Tumor Cell Radiosensitivity Cancer Res., November 1, 2003; 63(21): 7377 - 7383. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Russell, W. Burgan, K. A. Oswald, K. Camphausen, and P. J. Tofilon Enhanced Cell Killing Induced by the Combination of Radiation and the Heat Shock Protein 90 Inhibitor 17-Allylamino-17- Demethoxygeldanamycin: A Multitarget Approach to Radiosensitization Clin. Cancer Res., September 1, 2003; 9(10): 3749 - 3755. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Crowley-Weber, C. M. Payne, M. Gleason-Guzman, G. S. Watts, B. Futscher, C. N. Waltmire, C. Crowley, K. Dvorakova, C. Bernstein, M. Craven, et al. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate Carcinogenesis, December 1, 2002; 23(12): 2063 - 2080. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Russell and P. J. Tofilon Radiation-induced Activation of Nuclear Factor-kappa B Involves Selective Degradation of Plasma Membrane-associated Ikappa Balpha Mol. Biol. Cell, October 1, 2002; 13(10): 3431 - 3440. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |